文章摘要
高攀.疏肝宁胃汤联合奥美拉唑对慢性浅表性胃炎患者血清COX-2、Gas水平的影响[J].实用中西医结合临床,2022,22(5):
疏肝宁胃汤联合奥美拉唑对慢性浅表性胃炎患者血清COX-2、Gas水平的影响
Effect of gastric soup combined with omeprazole on serum COX-2 and Gas levels in patients with chronic superficial gastritis
投稿时间:2022-03-08  修订日期:2022-04-02
DOI:
中文关键词: [关键词] 慢性浅表性胃炎  疏肝宁胃汤  奥美拉唑  血清环氧化酶-2  胃泌素  中医证候积分
英文关键词: [Key words] Chronic superficial gastritis  gastric soup  omeprazole  serum cyclooxidase-2  gastrin  TCM syndrome integral
基金项目:
作者单位E-mail
高攀* 河南省新郑市中医院 x0e459@163.com 
摘要点击次数: 376
全文下载次数: 122
中文摘要:
      [摘要]目的 探究疏肝宁胃汤联合奥美拉唑对慢性浅表性胃炎(CSG)患者血清环氧化酶-2(COX-2)及胃泌素(Gas)水平的影响。方法 纳入88例2018年9月-2020年8月我院收治的CSG患者,依据随机数字表法分为研究组(n=44)及对照组(n=44)。对照组服用奥美拉唑,研究组在上述基础上联合疏肝宁胃汤,两组均治疗1个月。对比两组临床疗效、中医证候积分、血清COX-2、Gas水平、炎症因子[白介素-6(IL-6)及肿瘤坏死因子-α(TNF-α)]水平及不良反应。结果 治疗总有效率研究组为95.45%(42/44),高于对照组75.00%(33/44),有统计学差异(P<0.05);研究组治疗后胃脘胀痛积分[(1.02±0.21)分]、嗳气频繁积分[(1.05±0.26)分]、嘈杂泛酸积分[(0.98±0.10)分]、胆汁反流积分[(0.89±0.08)分]均低于对照组[(2.53±0.36)分、(2.49±0.30)分、(1.98±0.13)分、(1.65±0.11)分],有统计学差异(P<0.05);研究组治疗后COX-2水平[(5.43±0.76)IU/L]、Gas水平[(18.24±3.16)ng/L]均低于对照组[(9.87±1.05)IU/L、(27.20±2.87)ng/L],有统计学差异(P<0.05);研究组治疗后IL-6水平[(17.31±4.62)ng/L]、TNF-α水平[(19.51±4.19)ng/L]低于对照组[(20.52±4.81)ng/L、(25.57±5.52)ng/L],有统计学差异(P<0.05);不良反应研究组为4.55%(2/44),低于对照组的18.18%(8/44),有统计学差异(P<0.05)。结论 疏肝宁胃汤联合奥美拉唑在CSG患者治疗中有助于改善各临床症状,抑制炎症反应,降低COX-2、Gas水平,不良反应少,疗效确切,安全性高。
英文摘要:
      [Abstract] Objective To explore the effect of gastric soup combined with omeprazole on serum cyclooxygenase-2 (COX-2) and gastrin (Gas) levels in patients with chronic superficial gastritis (CSG).Methods 88 CSG patients admitted to our hospital from September 2018 to August 2020 were divided into study group (n=44) and control group (n=44) according to random numbers method.The control group was on omeprazole, the study group combined with gastric soup on the above basis, and both groups were treated for 1 month.The clinical efficacy, TCM syndrome score, serum COX-2, Gas levels, inflammatory factors [interleukin-6 (IL-6) and tumor necrosis factor- (TNF-)] levels and adverse effects were compared.Results The total response rate study group was 95.45% (42 / 44), Higher than the control group, 75.00% (33 / 44), Statistically different (P <0.05); The points [(1.02 ± 0.21)], frequent belching [(1.05 ± 0.26)], noisy pantothenic acid [(0.98 ± 0.10)], bile reflux [(0.89 ± 0.08)] were lower than the control group [(2.53 ± 0.36), (2.49 ± 0.30), (1.98 ± 0.13), (1.65 ± 0.11)], Statistically different (P <0.05); COX-2 [(5.43 ± 0.76) IU / L] and Gas [(18.24 ± 3.16) ng/L] were lower than the control group [(9.87 ± 1.05) IU / L, (27.20 ± 2.87) ng/L], Statistically different (P <0.05); IL-6 levels [(17.31 ± 4.62) ng/L], TNF-levels [(19.51 ± 4.19) ng/L] were lower than the control group [(20.52 ± 4.81) ng/L, (25.57 ± 5.52) ng/L], Statistically different (P <0.05); The adverse R study group was 4.55% (2 / 44), Less than 18.18% (8 / 44) of the control group, Statistical difference (P <0.05).Conclusion Combined with omeprazole can help to improve various clinical symptoms, inhibit inflammatory response, reduce COX-2 and Gas levels, with few adverse effects, definite efficacy and high safety.
查看全文   查看/发表评论  下载PDF阅读器
关闭
手机扫一扫看
分享按钮